Gufic Biosciences shares update on USFDA Pre-Approval Inspection at Indore plant. Company received 3 observations; remediation process is currently underway. Gufic Biosciences Faces USFDA Inspection Observations at Indore Plant 3 observations noted in USFDA Form 483. Inspection conducted between October 15 and October 23, 2026. Reader Takeaway: Regulatory scrutiny remains standard; investors should track the company’s remediation plan success for future product approvals.